DENVER--(BUSINESS WIRE)--VieCure today announced a new collaboration with Labcorp to provide clinicians greater access to precision oncology decision support. This strategic collaboration will support ...

Illumina, Inc. (NASDAQ: ILMN) today announced that reimbursement has been granted for its FDA-approved in vitro diagnostic ...

Making is Fueling Strong Growth in Pan-Genomic and Multi-Gene Panel Testing, Supported by Expanding NGS Access, Advanced ...

In Nigeria, SYNLAB Nigeria’s expansive medical test bouquet reflects how integrated testing is redefining the journey toward ...

Therapeutic decision making for patients with advanced non–small cell lung cancer (aNSCLC) includes a growing number of options for genomic, biomarker-guided, targeted therapies. We compared ...

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) ...

TAIPEI, Nov. 28, 2025 /PRNewswire/ -- Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI). Multi-Cancer Early Detection (MCED) has ...

Gone are the days when oncologists reacted to a cancer diagnosis by using the few drugs we had and hoping for the best. We have evolved from being reactive to proactive, primarily due to advances in ...

LONDON--(BUSINESS WIRE)-- Smiths Detection, a global leader in threat detection and security screening technologies, and a business of Smiths Group plc, today announces the launch of the SDX 6040 ...